A Phase 1b Dose-finding Study of DDFPe in Patients With Acute Ischemic Stroke.

Trial Profile

A Phase 1b Dose-finding Study of DDFPe in Patients With Acute Ischemic Stroke.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 24 Nov 2017

At a glance

  • Drugs Perflenapent (Primary)
  • Indications Stroke
  • Focus Adverse reactions
  • Most Recent Events

    • 06 Mar 2017 Status changed from not yet recruiting to recruiting, according to a NuvOx Pharma media release.
    • 17 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top